Skip to main content
. 2006 Aug;50(8):2762–2771. doi: 10.1128/AAC.00320-06

FIG. 6.

FIG. 6.

A. Active site of Toho-1 in complex with benzylpenicillin. B. Active site of M. tuberculosis BlaC with a docked ligand benzylpenicillin, using SwissPDB. C. Active site of E166A mutant SHV-1 in complex with the trans-enamine intermediate of tazobactam. D. Active site of M. tuberculosis BlaC with a docked intermediate of tazobactam, using SwissPDB.